Statement, September 2018
South Centre Statement for the Informal Consultation on the Roadmap on Access to Medicines
The draft roadmap is an important work in progress that needs to be further detailed with clear deliverables and timelines. The roadmap will need to ensure complementarity of its work and the implementation of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPOA).
Download the statement below:
This article was tagged: Access to Medicines, Affordable Medicines, Biosimilars, Generic Medicines, Global Health, Health, Innovation, Intellectual Property, Public Health, Research and Development (R&D), TRIPS, UN Secretary-General's High-Level Panel on Access to Medicines, WHO, WIPO, World Health Assembly (WHA), World Health Organization (WHO), World Intellectual Property Organization (WIPO), World Trade Organization (WTO), WTO